Safety and Feasibility of Same-Day Discharge After Primary Bariatric Surgery and the Value of Remote Monitoring with the Healthdot

初次减重手术后当日出院的安全性和可行性以及使用 Healthdot 进行远程监测的价值

阅读:1

Abstract

BACKGROUND: Annually, more than 12,500 bariatric procedures are performed in the Netherlands. Same-day discharge (SDD) has been implemented in several surgical procedures and was recently introduced in bariatric metabolic surgery (BMS). However, the best way to safely facilitate this introduction is a subject of debate. This study aims to assess the feasibility of SDD in selected patients undergoing primary BMS and the value of remote monitoring with a wireless vital sign monitoring system (Healthdot). METHODS: This retrospective study included all primary sleeve gastrectomy and Roux-en-Y gastric bypass procedures in the first year after the introduction of SDD in a large teaching hospital in the Netherlands. SDD patients were remotely monitored postoperatively for 7 days using the Healthdot which measured vital signs continuously. The primary outcome was the success rate of SDD. Secondary outcomes included readmissions, complication rate, and Healthdot alarms. RESULTS: Out of 813 consecutive primary bariatric procedures between March 2022 and March 2023, there were 514 eligible patients of whom 260 were scheduled for SDD. Successful SDD was achieved in 246 patients (94.6%). Eight patients were readmitted within 48 h resulting in a success rate of 91.5%. Among 217 patients (83.5%) who went home with the Healthdot device, 28 alarms occurred of which 26 did not have a complication. In 11 other patients, a complication occurred without any alarms during the 7-day period. CONCLUSIONS: SDD after primary bariatric procedures is considered safe if specific selection and discharge criteria are maintained. The Healthdot is found to be ineffective in predicting complications in this patient group.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。